Purchase Order 36C24424P0929
Award Date 9/11/24
Potential Completion Date 12/11/24
Potential Value $9K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Wilmington, DE 19805, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Exosome Diagnostics Inc., a subsidiary of Bio-Techne Corporation, was awarded a $450.9K delivery order by the Department of Veterans Affairs' Veterans Integrated Service Network 7 for ExoDx Prostate testing services. This is a firm fixed-price, non-set-aside delivery order under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II), with a performance period extending through March 31, 2031. The award reflects the contractor's sole-source status based on its...
- Exosome Diagnostics Inc., a Bio-Techne Corporation subsidiary based in Waltham, Massachusetts, received a $69,891.36 firm fixed-price task order from the Department of Veterans Affairs Veterans Integrated Service Network 1 (VISN 1) for ExoDx Prostate IntelliScore testing services. This contract, awarded January 15, 2024, with completion by December 14, 2024, represents a child task order issued against the company's parent Blanket Purchase Agreement valued at $1.35M. The ExoDx Prostate...
- Exosome Diagnostics Inc., a subsidiary of Bio-Techne Corporation, was awarded a $692,149.52 firm fixed-price delivery order by Veterans Integrated Service Network 6 (VISN 6) on May 13, 2022, for the provision of ExoDx Prostate (IntelliScore) testing services. The contract, which is a child award under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II), requires performance through September 30, 2026, at the Richmond, VA location. This non-invasive,...
- This federal contract award to Exosome Diagnostics Inc., a subsidiary of Bio-Techne Corporation, is for the delivery of 8 ProState Test IntelliScore Biopsies to the U.S. Department of Veterans Affairs (VA) VISN 2 network. The $17,284.96 firm fixed-price delivery order is placed under the Medical Laboratory Testing and Analysis Services GSA Schedule (FSS-621-II) contract and does not have a set-aside designation. Exosome Diagnostics, a for-profit organization specializing in advanced liquid...
- Exosome Diagnostics Inc., a subsidiary of Bio-Techne Corporation, was awarded a $384,026.72 firm fixed-price delivery order by Veterans Integrated Service Network 2 on October 1, 2024, for ExoDx Prostate Test IntelliScore biopsies at the Northport VA Medical Center in New York. The contract, which is a child award under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II), carries an ultimate completion date of September 30, 2029, and involves no set-aside...
- This is a $8,266.72 firm fixed price delivery order contract awarded to Exosome Diagnostics, Inc., a subsidiary of Bio-Techne Corporation, by the U.S. Department of Veterans Affairs (VA). The contract is for the provision of the ExoDx Prostate (IntelliScore) non-invasive, urine-based liquid biopsy test to support prostate cancer screening for veterans at the Northport VA Medical Center. This contract was awarded under the VA's Medical Laboratory Testing and Analysis Services Federal Supply...
- This is a Year 3 task order issued against a parent Blanket Purchase Agreement (BPA) held by Exosome Diagnostics Inc., a subsidiary of Bio-Techne Corporation specializing in advanced liquid biopsy diagnostic technologies. The task order, valued at $270K and awarded December 15, 2025, by Veterans Integrated Service Network 1 (VISN 1) under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II), will deliver approximately 360 ExoDx Prostate IntelliScore tests...
- Exosome Diagnostics Inc., a Bio-Techne Corporation subsidiary based in Waltham, Massachusetts, received a delivery order award from Veterans Integrated Service Network (VISN) 7 on April 1, 2021, for its ExoDx Prostate (IntelliScore) diagnostic testing services. The delivery order, valued at $438,951.68 on a firm fixed-price basis, is issued under the Medical Laboratory Testing and Analysis Services Federal Supply Schedule (FSS-621-II) and does not utilize a set-aside designation. Performance...
- Exosome Diagnostics Inc., a subsidiary of Bio-Techne Corporation, received a Blanket Purchase Agreement (BPA) call valued at $103,709.76 from Veterans Integrated Service Network 1 (VISN 1), a component of the Department of Veterans Affairs. The award, issued on December 15, 2024, is for the provision of ExoDx Prostate IntelliScore testing services, a non-invasive, urine-based liquid biopsy diagnostic test that analyzes exosomal RNA biomarkers to assess the risk of clinically significant prostate...
- This federal contract award is for the EXOSOME DX TESTING service provided by Exosome Diagnostics Inc., a subsidiary of Bio-Techne Corporation. The $37,576.00 firm-fixed-price delivery order was awarded by the Department of Veterans Affairs (VA) under the Medical Laboratory Testing and Analysis Services GSA Schedule contract. The contract supports the VA's prostate cancer screening initiatives for veterans, with Exosome Diagnostics supplying its ExoDx Prostate IntelliScore liquid biopsy test,...